Literature DB >> 1138834

The uterine and cardiovascular effects of salbutamol and practolol during labour.

D G McDevitt, R J Wallace, A Roberts, C R Whitfield.   

Abstract

Intravenous salbutamol, a beta-adrenoceptor stimulant, given to nine patients in normal labour, with continous monitoring of uterine activity and of the maternal and fetal cardiovascular systems, was shown to decrease uterine activity significantly; maternal and fetal heart rates were significantly increased, and maternal systolic and diastolic arterial pressures were significantly decreased during the infusion, although no treatment had to be discontinued because of these effects. Apart from worsening of low back pain during the infusion in one patients, subjective side-effects were trival. With the salbutamol infusion continued at an effective maintenance rate, the carioselective beta-adrenoceptor blocking drug, practolol, given intravenously, reduced the maternal heart rate (although not significantly) but it did not alter the fetal heart rate; it also appeared to interfere transiently with the inhibiting action of salbutamol on uterine activity, but cerevical dilatation was arrested until the salbutamol infusion was discontinued. At least in five patients, labour remained suppressed until oxytoxin was infused intravenously.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138834     DOI: 10.1111/j.1471-0528.1975.tb00667.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  6 in total

1.  Metabolic effects of oral salbutamol in late pregnancy.

Authors:  N O Lunell; J Wager; B B Fredholm; B Persson
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

2.  Actions of salbutamol in late pregnancy: plasma cyclic AMP, insulin and C-peptide, carbohydrate and lipid metabolites in diabetic and non-diabetic women.

Authors:  B B Fredholm; N O Lunell; B Persson; J Wager
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

3.  Management of premature labour in diabetic pregnancy.

Authors:  A H Barnett; S M Stubbs; A M Mander
Journal:  Diabetologia       Date:  1980-05       Impact factor: 10.122

4.  Salbutamol in the management of premature labour: a preliminary report.

Authors:  D H Martin; D G McDevitt
Journal:  Ir J Med Sci       Date:  1977-12       Impact factor: 1.568

5.  An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.

Authors:  P M McCaffrey; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

6.  Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.

Authors:  P J Phillips; A E Vedig; P L Jones; M G Chapman; M Collins; J B Edwards; T C Smeaton; B M Duncan
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.